Debut partners directly with brands to formulate high-performing skincare powered by DermCeutical Naringenin™ tailored to their specific product briefs.

Public source

Publisher name

Public post

DermCeutical Naringenin™ works by strengthening skin against the oxidative stress that contributes to inflammaging and visible signs of aging, supporting healthier, more…

Log in to read the full post

Company

Debut

The Leader in Biotech Beauty

Industry
Biotechnology Research
Location
San Diego, US
Company size
51–200 employees

About Debut

Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy. Named one of the TIME100 Most Innovative Companies 2025, Debut is redefining the beauty industry’s standards, centering on performance, potency and purity.

See more

Latest activity

8 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.